Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2012
In vitro model of invasive pulmonary aspergillosis in the human alveolusLea Gregson, William W Hope, Susan J HowardBMC Family Practice|May 31, 2020
More that unites us than divides us? A qualitative study of integration of community health and social care servicesClaire Mitchell, Abigail Tazzyman, Susan J Howard, et al.BMJ Open|August 15, 2020
Implementing post-discharge care following acute kidney injury in England: a single-centre qualitative evaluationRebecca Elvey, Susan J Howard, Anne-Marie Martindale, et al.Public Management Review|January 10, 2023
'Real-world' priority setting for service improvement in English primary care: a decentred approachRoman Kislov, Kath Checkland, Paul M Wilson, et al.Antimicrobial Agents and Chemotherapy|July 20, 2011
Cryptic species and azole resistance in the Aspergillus niger complexSusan J Howard, Elizabeth Harrison, Paul Bowyer, et al.Therapeutic Drug Monitoring|January 5, 2012
Posaconazole: the case for therapeutic drug monitoringSusan J Howard, Timothy W Felton, Alicia Gomez-Lopez, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 3, 2009
Azole-resistance in Aspergillus: proposed nomenclature and breakpointsPaul E Verweij, Susan J Howard, Willem J G Melchers, et al.Cold Spring Harbor Perspectives in Medicine|November 12, 2014
Mechanisms of Antifungal Drug ResistanceLeah E Cowen, Dominique Sanglard, Susan J Howard, et al.BMJ Open|November 11, 2017
Understanding the implementation of 'sick day guidance' to prevent acute kidney injury across a primary care setting in England: a qualitative evaluationAnne-Marie Martindale, Rebecca Elvey, Susan J Howard, et al.Antimicrobial Agents and Chemotherapy|August 21, 2013
Determination of isavuconazole susceptibility of Aspergillus and Candida species by the EUCAST methodSusan J Howard, Cornelia Lass-Flörl, Manuel Cuenca-Estrella, et al.Pageof 4